We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Localization of Pheochromocytomata by Caval Catheterization

Timothy S. Harrison, MD; John F. Seaton, BS; Joseph C. Cerny, MD; Joseph J. Bookstein, MD; John D. Bartlett Jr., MD
Arch Surg. 1967;95(3):339-343. doi:10.1001/archsurg.1967.01330150015003.
Text Size: A A A
Published online


THE DIAGNOSIS of pheochromocytoma, once troublesome and frequently elusive, can now be easily established with precision and confidence in practically all cases. Current biochemical techniques for the determination of free uninary epinephrine and levarterenol (norepinephrine) excretion and their metabolites are responsible for this improvement.

Comparable precision in the treatment of these chromaffin cell tumors is desirable and depends, in large part, on the accurate preoperative localization of the pheochromocytoma. Ectopic locations of pheochromocytomata in the chest, in the wall of the urinary bladder, and in the neck have all been reported.1-5 Roentgenographic techniques, especially plain abdominal and chest films, excretory pyelograms with nephrotomography, presacral gas insufflation, and, most recently, selective arteriography have all been used in localizing such tumors. A significant proportion of pheochromocytoma patients may be too ill for such vigorous diagnostic measures and others have lesions which are not vascular enough or are too small to be


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.